Clinical Pharmacology and Drug Toxicity Practice Questions

Q: Which triptan is available in nasal spray form?

Sumatriptan. ***Sumatriptan*** - **Sumatriptan** is available in multiple formulations, including **oral, subcutaneous injection, and nasal spray**, making it versatile for migraine treatment [1], [2]. - The nasal spray formulation allows for **faster absorption** and onset of action, which can be beneficial for patients with nausea or vomiting during migraine attacks [1]. *Rizatriptan* - **Rizatriptan** is primarily available in **oral tablet** and **orally disintegrating tablet** (ODT) forms [2]. - It does not have a commonly available nasal spray formulation for migraine treatment [2]. *Naratriptan* - **Naratriptan** is available as an **oral tablet** and is known for its **longer half-life** and generally milder side effect profile compared to sumatriptan [2]. - It is not available in a nasal spray formulation [2]. *Frovatriptan* - **Frovatriptan** is available exclusively as an **oral tablet** and is notable for having the **longest half-life** among triptans, making it useful for preventing recurring migraines [2]. - There is no nasal spray formulation for frovatriptan [2].

Q: Which of the following is not a known side effect of amiodarone?

Hyperglycemia. ***Hyperglycemia*** - **Hyperglycemia** is generally **not recognized** as a direct or common side effect of amiodarone. - Amiodarone's primary action is on cardiac ion channels, and its metabolic effects typically involve thyroid function, not glucose regulation. *Hyperthyroidism* - Amiodarone contains **iodine**, which can induce **thyroid dysfunction**, including both hypo- and hyperthyroidism. - **Amiodarone-induced hyperthyroidism (AIH)** can occur due to increased thyroid hormone synthesis or destructive thyroiditis. *Peripheral neuropathy* - **Neurological side effects**, including **peripheral neuropathy**, are known to occur with chronic amiodarone use. - Symptoms often include **paresthesias**, weakness, and sensory loss in the extremities. *Skin discoloration* - Prolonged use of amiodarone can lead to **bluish-gray skin discoloration**, particularly in sun-exposed areas. - This is due to the **accumulation of amiodarone** and its metabolites in the skin.

Q: Which local anaesthetic is known to cause methemoglobinemia?

Prilocaine. ***Prilocaine*** - **Prilocaine** is metabolized into **ortho-toluidine**, which can oxidize hemoglobin to **methemoglobin**, especially at higher doses or in susceptible individuals. - **Methemoglobinemia** symptoms include **cyanosis**, **dyspnea**, and in severe cases, central nervous system depression, due to reduced oxygen-carrying capacity of blood. *Procaine* - **Procaine** is an ester-type local anesthetic. It is metabolized to **para-aminobenzoic acid (PABA)**, which can cause allergic reactions, but it is not associated with methemoglobinemia. - It has a relatively **short duration of action** and is less commonly used now compared to amide-type local anesthetics. *Etidocaine* - **Etidocaine** is an amide-type local anesthetic that is known for its **long duration of action** and high potency. - While it can cause systemic toxicity with high doses due to its cardiac and neurological effects, **methemoglobinemia** is not a characteristic side effect. *Ropivacaine* - **Ropivacaine** is an amide-type local anesthetic similar to bupivacaine, known for its **motor-sparing effect** and use in regional anesthesia. - It is associated with a lower risk of **cardiotoxicity** compared to bupivacaine but does not cause methemoglobinemia.

Q: Which drug is most commonly associated with causing exanthema?

Sulfonamide. ***Sulfonamide*** - **Sulfonamides** are among the **most common causes** of drug-induced exanthema (maculopapular/morbilliform rash). - They account for a significant proportion of cutaneous adverse drug reactions, with exanthema being the most frequent presentation. - The mechanism typically involves a **delayed hypersensitivity reaction** (Type IV) to the drug or its metabolites. - **Classic presentation:** Symmetrical, erythematous, maculopapular rash appearing 7-14 days after drug initiation. *Phenytoin* - **Phenytoin** can cause exanthematous eruptions, but it is more notably associated with **severe cutaneous adverse reactions** such as: - **DRESS syndrome** (Drug Reaction with Eosinophilia and Systemic Symptoms) - **Stevens-Johnson syndrome (SJS)** and **Toxic Epidermal Necrolysis (TEN)** - While exanthema can occur, **sulfonamides** are more frequently implicated in simple morbilliform rashes. *Atropine* - **Atropine** is an anticholinergic agent primarily causing **predictable pharmacological effects**: - Dry mouth, mydriasis, tachycardia, urinary retention - **Allergic skin reactions** with atropine are rare and not a characteristic adverse effect. - Atropine is **not recognized** as a common cause of exanthema. *All of the options* - This is incorrect because **atropine** is not commonly associated with exanthema. - While both sulfonamides and phenytoin can cause exanthema, only **sulfonamides** are considered among the **most common** causes.

Q: Which drug is most commonly associated with causing fixed drug eruptions?

Sulfonamide. ***Sulfonamide*** - **Sulfonamides**, particularly **sulfamethoxazole-trimethoprim**, are frequently implicated in causing fixed drug eruptions. - A fixed drug eruption characteristically recurs at the **same cutaneous site** each time the offending drug is administered. *Aminoglycoside* - **Aminoglycosides** are broad-spectrum antibiotics known for potential **ototoxicity** and **nephrotoxicity**. - While they can cause various adverse reactions, fixed drug eruptions are **not a common association** with this drug class. *Erythromycin* - **Erythromycin** is a macrolide antibiotic primarily associated with **gastrointestinal side effects**, such as nausea and abdominal cramping. - Although drug eruptions can occur, fixed drug eruptions are **not typically linked** to erythromycin. *None of the options* - This option is incorrect because **sulfonamides** are well-documented causes of fixed drug eruptions. - Therefore, there is a specific drug class listed that is strongly associated with this condition.

Q: Which of the following antiglaucoma medications can cause drowsiness?

Brimonidine. ***Brimonidine*** - **Brimonidine** is an **alpha-2 adrenergic agonist** [1] that can cause central nervous system depression, leading to side effects such as **drowsiness** and fatigue. - This systemic side effect is more common with the topical ophthalmic formulation due to systemic absorption. *Latanoprost* - **Latanoprost** is a **prostaglandin analog** that primarily works by increasing uveoscleral outflow, and its side effects are mainly localized to the eye (e.g., iris color change, eyelash growth). - It does not typically cause systemic side effects like drowsiness because its systemic absorption is minimal. *Dorzolamide* - **Dorzolamide** is a **topical carbonic anhydrase inhibitor** [1] that reduces aqueous humor production, and its most common side effects include local ocular irritation and a bitter taste. - While systemic carbonic anhydrase inhibitors can cause fatigue and drowsiness, the topical formulation has very limited systemic absorption, making drowsiness uncommon. *Timolol* - **Timolol** is a **non-selective beta-blocker** [1] that reduces aqueous humor production and can cause systemic side effects such as bradycardia, bronchospasm, and hypotension. - While some beta-blockers can cause fatigue, **drowsiness** as a prominent side effect is less common compared to alpha-2 agonists.

Q: Visual field monitoring is important before starting which of the following drugs for epilepsy treatment?

Vigabatrin. ***Vigabatrin*** - **Vigabatrin** is known to cause **irreversible concentric visual field constriction** (peripheral vision loss) due to retinal toxicity. - Regular **ophthalmological monitoring**, including **visual field testing**, is crucial before and during treatment to detect and manage this adverse effect early. *Topiramate* - Topiramate can cause **acute angle-closure glaucoma** and **myopia**, which affect vision, but regular visual field monitoring is not a primary requirement for this specific side effect. - Its main concerns often relate to cognitive side effects and kidney stones, rather than progressive visual field loss requiring baseline and ongoing field testing. *Valproic acid* - Valproic acid is not typically associated with specific visual field defects requiring routine monitoring. - Its major side effects often involve **hepatotoxicity**, **pancreatitis**, and **teratogenicity**. *Carbamazepine* - Carbamazepine's notable side effects include **aplastic anemia**, **hyponatremia**, and **Stevens-Johnson syndrome**. - While it can cause some ocular side effects like **diplopia** or **nystagmus**, it does not typically lead to the progressive and irreversible visual field constriction seen with vigabatrin, which necessitates strict monitoring.

Q: All of the following are adverse effects of nicotinic acid except:

Pancreatitis. ***Pancreatitis*** - **Pancreatitis** is not a commonly reported adverse effect of nicotinic acid (niacin) therapy. - While other gastrointestinal side effects like nausea and vomiting can occur, pancreatic inflammation is not characteristic. *Vasodilation* - **Cutaneous flushing** and **vasodilation** are very common adverse effects of nicotinic acid, mediated by prostaglandin release. - This effect can cause a sensation of warmth, redness, and itching, especially at the start of therapy. *Liver dysfunction* - **Liver dysfunction**, including elevated liver enzymes and rare cases of **hepatotoxicity**, can occur with high doses of nicotinic acid. - Regular monitoring of liver function tests is recommended for patients on niacin therapy. *Hyperpigmentation* - **Hyperpigmentation**, particularly **acanthosis nigricans**, is a known cutaneous side effect of nicotinic acid. - This typically presents as dark, velvety patches on the skin, especially in skin fold areas.

Q: What is the most serious side effect associated with Raltegravir?

Rhabdomyolysis. ***Rhabdomyolysis*** - Raltegravir, an **integrase strand transfer inhibitor (INSTI)**, can cause muscle-related side effects, including **rhabdomyolysis** and **myopathy**. [2] - Patients may present with muscle pain, weakness, and elevated **creatine kinase (CK)** levels. *Headache* - While headache can be a general side effect of many medications, it is not a **distinguishing or severe adverse effect commonly associated with Raltegravir** that would require specific monitoring. - Other more prominent side effects are typically prioritized in counseling and monitoring for this drug. *Hyperglycemia* - **Hyperglycemia** is not a commonly reported or significant side effect of Raltegravir. - While some antiretrovirals, particularly certain **protease inhibitors (PIs)** and **nucleoside reverse transcriptase inhibitors (NRTIs)**, are associated with altered glucose metabolism, INSTIs like Raltegravir generally have a more favorable metabolic profile. [1] *Hypertension* - Hypertension is generally **not a recognized or common side effect** of Raltegravir. - Cardiovascular events and hypertension are more frequently associated with other classes of antiretroviral drugs or as comorbidities in HIV-positive patients, rather than directly with INSTIs.

Q: Which of the following antiretroviral drugs is not associated with peripheral neuropathy?

Indinavir. ***Indinavir*** - **Indinavir** is a **protease inhibitor** that can cause side effects such as **nephrolithiasis** (kidney stones) and **hyperbilirubinemia**, but it is generally *not associated with peripheral neuropathy*. - It works by blocking the viral protease enzyme, preventing the cleavage of viral polyproteins into functional proteins, which disrupts viral replication. *Stavudine* - **Stavudine** is a **nucleoside reverse transcriptase inhibitor (NRTI)** notorious for causing dose-dependent **peripheral neuropathy**. - This toxicity is due to its interference with **mitochondrial DNA synthesis**, leading to nerve damage. *Zalcitabine* - **Zalcitabine** (ddC) is another **NRTI** strongly associated with a high incidence of **peripheral neuropathy**. - Its mechanism of action and side effect profile are similar to those of stavudine in causing **mitochondrial toxicity**. *Didanosine* - **Didanosine** (ddI) is an **NRTI** known to cause several adverse effects, including **peripheral neuropathy**, particularly at higher doses. - Like other dideoxynucleoside analogs, its toxicity is linked to **mitochondrial dysfunction**.

Question 1

Which triptan is available in nasal spray form?

Accepted Answer

Sumatriptan

Answer

Rizatriptan

Answer

Naratriptan

Answer

Frovatriptan

Question 2

Which of the following is not a known side effect of amiodarone?

Accepted Answer

Hyperglycemia

Answer

Peripheral neuropathy

Answer

Hyperthyroidism

Answer

Skin discoloration

Question 3

Which local anaesthetic is known to cause methemoglobinemia?

Accepted Answer

Prilocaine

Answer

Procaine

Answer

Ropivacaine

Answer

Etidocaine

Question 4

Which drug is most commonly associated with causing exanthema?

Accepted Answer

Sulfonamide

Answer

Atropine

Answer

Phenytoin

Answer

All of the options

Question 5

Which drug is most commonly associated with causing fixed drug eruptions?

Accepted Answer

Sulfonamide

Answer

Aminoglycoside

Answer

Erythromycin

Answer

None of the options

Question 6

Which of the following antiglaucoma medications can cause drowsiness?

Accepted Answer

Brimonidine

Answer

Latanoprost

Answer

Dorzolamide

Answer

Timolol

Question 7

Visual field monitoring is important before starting which of the following drugs for epilepsy treatment?

Accepted Answer

Vigabatrin

Answer

Topiramate

Answer

Valproic acid

Answer

Carbamazepine

Question 8

All of the following are adverse effects of nicotinic acid except:

Accepted Answer

Pancreatitis

Answer

Liver dysfunction

Answer

Vasodilation

Answer

Hyperpigmentation

Question 9

What is the most serious side effect associated with Raltegravir?

Accepted Answer

Rhabdomyolysis

Answer

Hyperglycemia

Answer

Hypertension

Answer

Headache

Question 10

Which of the following antiretroviral drugs is not associated with peripheral neuropathy?

Accepted Answer

Indinavir

Answer

Stavudine

Answer

Zalcitabine

Answer

Didanosine

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?